VARIANT II HEMOGLOBIN A1C

Assay, Glycosylated Hemoglobin

BIO-RAD LABORATORIES, INC.

The following data is part of a premarket notification filed by Bio-rad Laboratories, Inc. with the FDA for Variant Ii Hemoglobin A1c.

Pre-market Notification Details

Device IDK040872
510k NumberK040872
Device Name:VARIANT II HEMOGLOBIN A1C
ClassificationAssay, Glycosylated Hemoglobin
Applicant BIO-RAD LABORATORIES, INC. 4000 ALFRED NOBEL DR. Hercules,  CA  94547
ContactJackie Buckley
CorrespondentAlfredo J Quattrone
CALIFORNIA DEPARTMENT OF HEALTH SERVICES 1500 CAPITOL AVENUE MAILSTOP 7602 Sacramento,  CA  95814
Product CodeLCP  
CFR Regulation Number864.7470 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedYes
Combination ProductNo
Date Received2004-04-02
Decision Date2004-04-15
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00847817014154 K040872 000
00847817000416 K040872 000
00847817000461 K040872 000
00847817010613 K040872 000
00847817013904 K040872 000
00847817013928 K040872 000
00847817013966 K040872 000
00847817014079 K040872 000
00847817014093 K040872 000
00847817000409 K040872 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.